quinoline has been researched along with Neoplasms in 28 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (21.43) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (10.71) | 29.6817 |
| 2010's | 11 (39.29) | 24.3611 |
| 2020's | 8 (28.57) | 2.80 |
| Authors | Studies |
|---|---|
| Strassburg, CP; Tukey, RH | 1 |
| Bharate, SB; Mudududdla, R; Nuthakki, VK | 1 |
| Sharma, S; Singh, S; Yadav, D | 1 |
| Ausekle, E; Ejaz, SA; Iqbal, J; Khan, I; Langer, P; Miliutina, M | 1 |
| Andrade, CH; Custodio, JMF; D'Oliveira, GDC; Filho, JTM; Junior, PSC; Napolitano, HB; Neves, BJ; Perez, CN; Silveira-Lacerda, EP; Vaz, WF | 1 |
| Ding, Z; Zeng, C; Zhou, M | 1 |
| Atukuri, D; L, V; M M, R; R, P; R, S; S, V | 1 |
| Bassi, G; Biancofiore, I; Cazzamalli, S; Dakhel Plaza, S; Donckele, EJ; Elsayed, A; Gloger, A; Millul, J; Mock, J; Nadal, L; Neri, D; Pellegrino, C; Samain, F; Schmidt, E; Zana, A | 1 |
| Altmann, A; Giesel, F; Haberkorn, U; Kratochwil, C | 1 |
| Kukowska, M | 1 |
| Fukushima, S; Kano, H; Matsumoto, M; Noguchi, T; Suzuki, M; Umeda, Y | 1 |
| Chu, XM; Gong, KK; Liang, LL; Liu, W; Sun, KL; Wang, C; Zhao, CY | 1 |
| Chong, KT; Funabashi, K; Kawai, Y; Kitade, M; Kodama, Y; Mizutani, T; Muraoka, H; Ohkubo, M; Ohkubo, S; Oshiumi, H; Shigeno, K; Suzuki, T; Takahashi, K; Uno, T; Yamashita, S; Yoshimura, C | 1 |
| Chen, K; Qi, S; Wang, B; Wang, L; Wang, W; Yang, J | 1 |
| Akkenapally, S; Kapavarapu, R; Kumar, CG; Murthy, NY; Pal, S; Praveena, KS; Shivaji Ramarao, EV | 1 |
| Guo, J; Guo, Z; James, TD; Shao, A; Shi, P; Tian, H; Xie, Y; Zhu, S; Zhu, WH | 1 |
| He, Q; Hu, Y; Lv, X; Ma, X; Qiu, N; Yang, B | 1 |
| Czaplinska, B; Malarz, K; Mrozek-Wilczkiewicz, A; Musiol, R; Musioł, M; Pastuch-Gawołek, G; Serda, M | 1 |
| Akhtar, N; Jabeen, I | 1 |
| Hambley, TW; Madawala, R; New, EJ; Roche, C; Zhang, JZ | 1 |
| Bednarski, PJ; Eick, A; Grünert, R; Riechert-Krause, F; Weisz, K | 1 |
| AKAGI, S; FUKUOKA, F; MINODA, K; SAITO, G; SAKAI, S; UENO, A | 1 |
| FUKUOKA, F; NAORA, H | 1 |
| FUKUOKA, F | 1 |
| KANAZAWA, K | 1 |
| BAHNER, CT | 1 |
| BREUNINGER, ER; CREECH, HJ; MILLER, AJ; PECK, RM | 1 |
| Kaur, P; Kaur, S; Kumar, S; Luxami, V; Singh, P | 1 |
7 review(s) available for quinoline and Neoplasms
| Article | Year |
|---|---|
Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
Topics: Autoimmunity; Chromosome Mapping; Glucuronides; Glucuronosyltransferase; Humans; Hyperbilirubinemia; Neoplasms; Steroids; Terminology as Topic | 2000 |
Role of basic aminoalkyl chains in the lead optimization of Indoloquinoline alkaloids.
Topics: Alkaloids; Antimalarials; Antineoplastic Agents; Cell Proliferation; Indoles; Malaria; Molecular Structure; Neoplasms; Quinolines | 2022 |
Recent advances in isatin hybrids as potential anticancer agents.
Topics: Animals; Antineoplastic Agents; Azoles; Cell Proliferation; Drug Screening Assays, Antitumor; Humans; Imines; Isatin; Molecular Structure; Neoplasms; Quinolines; Structure-Activity Relationship | 2020 |
Identification of quinoline-chalcones and heterocyclic chalcone-appended quinolines as broad-spectrum pharmacological agents.
Topics: Anti-Infective Agents; Antineoplastic Agents; Chalcones; Heterocyclic Compounds; Humans; Infections; Molecular Structure; Neoplasms; Quinolines | 2020 |
Ligand engineering for theranostic applications.
Topics: Animals; Antineoplastic Agents; Diagnostic Imaging; Endopeptidases; Enzyme Inhibitors; Helianthus; Humans; Ligands; Membrane Proteins; Molecular Targeted Therapy; Neoplasms; Peptide Fragments; Peptide Library; Peptides; Positron-Emission Tomography; Precision Medicine; Quinolines; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon; Trypsin Inhibitors | 2021 |
Amino acid or peptide conjugates of acridine/acridone and quinoline/quinolone-containing drugs. A critical examination of their clinical effectiveness within a twenty-year timeframe in antitumor chemotherapy and treatment of infectious diseases.
Topics: Acridines; Acridones; Amino Acids; Animals; Anti-Infective Agents; Antineoplastic Agents; Communicable Diseases; Humans; Neoplasms; Peptides; Quinolines; Quinolones; Treatment Outcome | 2017 |
Quinoline and quinolone dimers and their biological activities: An overview.
Topics: Anti-Bacterial Agents; Antimalarials; Antineoplastic Agents; Bacteria; Dimerization; Humans; Neoplasms; Quinolines; Quinolones | 2019 |
21 other study(ies) available for quinoline and Neoplasms
| Article | Year |
|---|---|
Quinoline-based Anti-oncogenic Molecules: Synthesis and Biological Evaluation.
Topics: Antineoplastic Agents; Humans; Indicators and Reagents; Neoplasms; Quinolines | 2023 |
Exploration of quinolone and quinoline derivatives as potential anticancer agents.
Topics: Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; DNA Fragmentation; Drug Screening Assays, Antitumor; HeLa Cells; Humans; K562 Cells; MCF-7 Cells; Neoplasms; Quinolines; Quinolones | 2019 |
Dihydroquinoline derivative as a potential anticancer agent: synthesis, crystal structure, and molecular modeling studies.
Topics: Animals; Antineoplastic Agents; Cell Line; Cell Line, Tumor; Cell Proliferation; Chlorocebus aethiops; Crystallography, X-Ray; Drug Screening Assays, Antitumor; Heterocyclic Compounds; Humans; Mice; Models, Molecular; Molecular Docking Simulation; Neoplasms; Quinolines; Quinolones; Structure-Activity Relationship; Vero Cells | 2021 |
An ultra-high-affinity small organic ligand of fibroblast activation protein for tumor-targeting applications.
Topics: Animals; Cell Line, Tumor; Drug Delivery Systems; Endopeptidases; Fibroblasts; Gene Expression; Gene Expression Regulation, Neoplastic; Isotope Labeling; Ligands; Lutetium; Male; Membrane Proteins; Mice; Mice, Nude; Neoplasms; Quinolines; Radioisotopes; Radiopharmaceuticals; Tissue Distribution; Xenograft Model Antitumor Assays | 2021 |
Carcinogenicity of quinoline by drinking-water administration in rats and mice.
Topics: Administration, Oral; Animals; Carcinoma, Hepatocellular; Drinking Water; Female; Hemangiosarcoma; Liver Neoplasms; Male; Mice, Inbred Strains; Mutagenesis; Neoplasms; Quinolines; Rats, Inbred F344; Specific Pathogen-Free Organisms | 2018 |
Discovery of 3-Ethyl-4-(3-isopropyl-4-(4-(1-methyl-1 H-pyrazol-4-yl)-1 H-imidazol-1-yl)-1 H-pyrazolo[3,4- b]pyridin-1-yl)benzamide (TAS-116) as a Potent, Selective, and Orally Available HSP90 Inhibitor.
Topics: Administration, Oral; Animals; Antineoplastic Agents; Benzamides; Binding Sites; Cell Line, Tumor; Crystallography, X-Ray; Drug Design; Drug Screening Assays, Antitumor; HSP90 Heat-Shock Proteins; Humans; Mice; Mice, Nude; Molecular Conformation; Molecular Dynamics Simulation; Neoplasms; Pyrazoles; Quinolines; Recombinant Proteins; Solubility; Structure-Activity Relationship | 2019 |
Design, synthesis, and biological activity of TLR7-based compounds for chemotherapy-induced alopecia.
Topics: Alopecia; Animals; Anti-Inflammatory Agents; Antineoplastic Agents; Apoptosis; Cell Proliferation; Cells, Cultured; Cytokines; Drug Design; Humans; Mice; Mice, Inbred BALB C; Molecular Docking Simulation; Neoplasms; Quinolines; Signal Transduction; Toll-Like Receptor 7 | 2020 |
Design of new hybrid template by linking quinoline, triazole and dihydroquinoline pharmacophoric groups: A greener approach to novel polyazaheterocycles as cytotoxic agents.
Topics: Antineoplastic Agents; Aza Compounds; Azides; Cell Line, Tumor; Drug Design; Green Chemistry Technology; Humans; Molecular Docking Simulation; Neoplasms; Phosphodiesterase 4 Inhibitors; Quinolines; Triazoles | 2015 |
Far-Red and Near-IR AIE-Active Fluorescent Organic Nanoprobes with Enhanced Tumor-Targeting Efficacy: Shape-Specific Effects.
Topics: Animals; Fluorescent Dyes; Infrared Rays; Mice; Models, Molecular; Nanostructures; Neoplasms; Nitriles; Optical Imaging; Quinolines; Whole Body Imaging | 2015 |
Discovery of novel quinoline-based mTOR inhibitors via introducing intra-molecular hydrogen bonding scaffold (iMHBS): The design, synthesis and biological evaluation.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Drug Design; HCT116 Cells; Humans; Hydrogen Bonding; MCF-7 Cells; Mechanistic Target of Rapamycin Complex 1; Mechanistic Target of Rapamycin Complex 2; Molecular Docking Simulation; Multiprotein Complexes; Neoplasms; Phosphatidylinositol 3-Kinases; Protein Kinase Inhibitors; Quinolines; Signal Transduction; TOR Serine-Threonine Kinases | 2015 |
Small molecule glycoconjugates with anticancer activity.
Topics: Apoptosis; Coordination Complexes; Copper; DNA; Glycoconjugates; HCT116 Cells; Humans; Intercalating Agents; Neoplasms; Quinolines; Reactive Oxygen Species; Zinc | 2016 |
A 2D-QSAR and Grid-Independent Molecular Descriptor (GRIND) Analysis of Quinoline-Type Inhibitors of Akt2: Exploration of the Binding Mode in the Pleckstrin Homology (PH) Domain.
Topics: Amino Acids; Antineoplastic Agents; Binding Sites; Humans; Hydrogen Bonding; Neoplasms; Pleckstrin Homology Domains; Protein Isoforms; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins c-akt; Quantitative Structure-Activity Relationship; Quinolines | 2016 |
Fluorescent analogues of quinoline reveal amine ligand loss from cis and trans platinum(II) complexes in cancer cells.
Topics: Amines; Antineoplastic Agents; Cell Line, Tumor; Fluorescent Dyes; Humans; Ligands; Molecular Structure; Neoplasms; Platinum Compounds; Quinolines; Sulfur | 2009 |
In vitro anticancer activity and evaluation of DNA duplex binding affinity of phenyl-substituted indoloquinolines.
Topics: Antineoplastic Agents; Cell Line, Tumor; Circular Dichroism; DNA; Drug Screening Assays, Antitumor; Humans; Indoles; Intercalating Agents; Neoplasms; Quinolines; Spectrometry, Fluorescence; Transition Temperature | 2011 |
On the anti-cancer action of quinoline derivatives.
Topics: Animals; Humans; Neoplasms; Neoplasms, Experimental; Quinolines | 1955 |
Inhibition of P 32 incorporation in vitro into nucleic acids of Ehrlich carcinoma cells by quinoline derivatives.
Topics: Antineoplastic Agents; In Vitro Techniques; Neoplasms; Nucleic Acids; Phosphorus; Quinolines | 1957 |
The effect on animal tumors of quinoline derivatives, especially 4-nitro-6-carboxy-quinoline-1-oxide.
Topics: Animals; Antineoplastic Agents; Humans; Neoplasms; Oxides; Quinolines | 1959 |
[STUDIES ON EXPERIMENTAL CANCER IN THE STOMACH GLANDS OF RATS, WITH SPECIAL REFERENCE TO LOCAL CHANGES CAUSED BY THE SUBMUCOSAL INSERTION IN THE STOMACH WALL OF 20-METHYLCHOLANTHRENE AND SUBCUTANEOUS INJECTION OF 4-NITRO-QUINOLINE N-OXIDE].
Topics: Adenocarcinoma; Antineoplastic Agents; Gastric Mucosa; Injections, Subcutaneous; Methylcholanthrene; Neoplasms; Neoplasms, Experimental; Oxides; Pathology; Quinolines; Rats; Research; Stomach Neoplasms | 1964 |
SOME EFFECTS OF MODIFICATIONS OF THE AMINOSTYRYL PORTION OF 4-(4-DIMETHYLAMINOSTYRYL)QUINOLINE.
Topics: Antineoplastic Agents; Carcinoma 256, Walker; Lymphoma; Neoplasms; Neoplasms, Experimental; Pharmacology; Quinolines; Rats; Research | 1964 |
ACRIDINE AND QUINOLINE ANALOGS OF NITROGEN MUSTARD WITH AMIDE SIDE CHAINS.
Topics: Acridines; Amides; Animals; Chemistry, Pharmaceutical; Mechlorethamine; Mice; Neoplasms; Neoplasms, Experimental; Nitrogen Mustard Compounds; Pharmacology; Quinolines; Research | 1964 |
Syntheses and anti-cancer activities of 2-[1-(indol-3-yl-/pyrimidin-5-yl-/pyridine-2-yl-/quinolin-2-yl)-but-3-enylamino]-2-phenyl-ethanols.
Topics: Antineoplastic Agents; Cell Proliferation; Drug Screening Assays, Antitumor; Humans; Indoles; Molecular Structure; Neoplasms; Pyridines; Pyrimidines; Quinolines; Structure-Activity Relationship; Tumor Cells, Cultured | 2007 |